Krsnaa Diagnostics (NSE:KRSNAA) Piotroski F-Score: 7 (As of Jul. 01, 2026) — 17% Above Median


NSE:KRSNAA Krsnaa Diagnostics Ltd NSE:KRSNAA
71 GF Score
Price ₹543.80
GF Value ₹899.38
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Krsnaa Diagnostics Piotroski F-Score?

Krsnaa Diagnostics NSE:KRSNAA +1.26% 71 Piotroski F-Score is 7 as of Jul. 01, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates NSE:KRSNAA with a GF Score™ of 71/100 and a GF Value™ of ₹899.38 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 210 Medical Diagnostics & Research companies, Krsnaa Diagnostics ranks better than 94.29% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Krsnaa Diagnostics has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Krsnaa Diagnostics's Piotroski F-Score or its related term are showing as below:

NSE:KRSNAA' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 7

During the past 8 years, the highest Piotroski F-Score of Krsnaa Diagnostics was 8. The lowest was 3. And the median was 6.

Krsnaa Diagnostics  (NSE:KRSNAA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Krsnaa Diagnostics Piotroski F-Score Related Terms


Krsnaa Diagnostics Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Krsnaa Diagnostics's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics Piotroski F-Score Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial 8.00 5.00 3.00 6.00 7.00

Krsnaa Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 0.00 0.00 0.00 7.00

NSE:KRSNAA vs TMO, DHR, IDXX: Piotroski F-Score Comparison

For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krsnaa Diagnostics Piotroski F-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Krsnaa Diagnostics's Piotroski F-Score falls into.


NSE:KRSNAA
71GF Score
Krsnaa Diagnostics Ltd NSE:KRSNAA
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹1,014 Mil.
Cash Flow from Operations was ₹1,431 Mil.
Revenue was ₹7,728 Mil.
Gross Profit was ₹5,320 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (12815.95 + 18237.16) / 2 = ₹15526.555 Mil.
Total Assets at the begining of this year (Mar25) was ₹12,816 Mil.
Long-Term Debt & Capital Lease Obligation was ₹4,683 Mil.
Total Current Assets was ₹7,383 Mil.
Total Current Liabilities was ₹2,752 Mil.
Net Income was ₹776 Mil.

Revenue was ₹7,172 Mil.
Gross Profit was ₹4,872 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (11719.13 + 12815.95) / 2 = ₹12267.54 Mil.
Total Assets at the begining of last year (Mar24) was ₹11,719 Mil.
Long-Term Debt & Capital Lease Obligation was ₹472 Mil.
Total Current Assets was ₹4,145 Mil.
Total Current Liabilities was ₹3,054 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Krsnaa Diagnostics's current Net Income (TTM) was 1,014. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Krsnaa Diagnostics's current Cash Flow from Operations (TTM) was 1,431. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1014.31/12815.95
=0.07914435

ROA (Last Year)=Net Income/Total Assets (Mar24)
=776.08/11719.13
=0.06622335

Krsnaa Diagnostics's return on assets of this year was 0.07914435. Krsnaa Diagnostics's return on assets of last year was 0.06622335. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Krsnaa Diagnostics's current Net Income (TTM) was 1,014. Krsnaa Diagnostics's current Cash Flow from Operations (TTM) was 1,431. ==> 1,431 > 1,014 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=4682.93/15526.555
=0.30160779

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=471.56/12267.54
=0.03843965

Krsnaa Diagnostics's gearing of this year was 0.30160779. Krsnaa Diagnostics's gearing of last year was 0.03843965. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=7383.4/2752.01
=2.68291176

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=4144.72/3053.88
=1.35719806

Krsnaa Diagnostics's current ratio of this year was 2.68291176. Krsnaa Diagnostics's current ratio of last year was 1.35719806. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Krsnaa Diagnostics's number of shares in issue this year was 32.847. Krsnaa Diagnostics's number of shares in issue last year was 32.941. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=5320.21/7727.74
=0.68845613

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4872.23/7171.6
=0.67937838

Krsnaa Diagnostics's gross margin of this year was 0.68845613. Krsnaa Diagnostics's gross margin of last year was 0.67937838. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=7727.74/12815.95
=0.60297832

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=7171.6/11719.13
=0.61195669

Krsnaa Diagnostics's asset turnover of this year was 0.60297832. Krsnaa Diagnostics's asset turnover of last year was 0.61195669. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+1+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Krsnaa Diagnostics has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Krsnaa Diagnostics (NSE:KRSNAA) has a Piotroski F-Score of 7 as of Jul. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Krsnaa Diagnostics and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Krsnaa Diagnostics' Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Krsnaa Diagnostics ranks #12 out of 210 companies in the Medical Diagnostics & Research industry, placing it in the top 5.7%.
Is Krsnaa Diagnostics' Piotroski F-Score too high?
Krsnaa Diagnostics' current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Medical Diagnostics & Research industry median Piotroski F-Score is 5.00. Krsnaa Diagnostics' value of 7 is 40% above this industry median. Based on the distribution chart, Krsnaa Diagnostics ranks #12 out of 210 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Krsnaa Diagnostics has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Piotroski F-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #12 out of 210 companies for Piotroski F-Score. This places Krsnaa Diagnostics in the top 6% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Krsnaa Diagnostics' value of 7 is 40% above this benchmark. Historically, Krsnaa Diagnostics' own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Krsnaa Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Diagnostics & Research company?
The median Piotroski F-Score among Medical Diagnostics & Research companies is 5.00, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krsnaa Diagnostics's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Krsnaa Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹899.38, compared to a current price of ₹543.80 — trading 39.5% below its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Medical Diagnostics & Research industry median of 5.00. Krsnaa Diagnostics' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Piotroski F-Score is 7 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?

Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued. The current stock price of ₹543.80 is trading 39.5% below its estimated GF Value™ of ₹899.38. GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.

Key valuation signals for NSE:KRSNAA:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: ₹899.38 vs. price of ₹543.80 (39.5% below fair value)
  • GF Score™: 71/100 with 5 warning signs
  • Industry Position: 40% above the Medical Diagnostics & Research median (#12 of 210)

No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krsnaa Diagnostics Business Description

Other Exchanges 543328:India
Address S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
71GF Score

Get the complete analysis for NSE:KRSNAA

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹543.80
Price
₹899.38
GF Value